Rubicon Research Ltd is Rated Buy by MarketsMOJO
2026-11-14 10:10:41Rubicon Research Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 05 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook.
Read MoreRubicon Research Gains 3.02% Despite Intraday Pressure: 2 Key Factors Driving the Week
2026-11-07 09:02:40Key Events This Week Nov 2: Stock rallies 3.71% on strong volume Nov 3: Continued gains of 2.79% amid positive market sentiment Nov 6: Intraday low hit amid price pressure, stock falls 4.70% Nov 6: Q2 FY27 results announced showing stellar growth but valuation concerns Week OpenRs.1,609.90 Week Close<div class="stat-v...
Read MoreRubicon Research Ltd Hits Intraday Low Amid Price Pressure on 6 Nov 2026
2026-11-06 14:47:27Rubicon Research Ltd experienced a notable decline on 6 Nov 2026, hitting an intraday low of Rs 1,614.6, reflecting a sharp price pressure of -7.22% during the trading session. This downturn contrasts with the broader market's positive momentum, as the Sensex advanced by 1.57%.
Read MoreRubicon Research Ltd is Rated Strong Buy
2026-11-03 10:11:32Rubicon Research Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 November 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreRubicon Research Ltd is Rated Strong Buy
2026-10-23 10:10:46Rubicon Research Ltd is rated Strong Buy by MarketsMOJO, a rating that was last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 October 2026, providing investors with the most up-to-date insight into its performance and outlook.
Read More139% Stock Return, 18% Profit Growth: What’s Driving Rubicon Research Ltd’s Multibagger Rerating?
2026-10-16 09:40:04A 139.31% stock return in one year. An 18% growth in net profit over the same period. The gap between those two numbers — roughly 121 percentage points — is driven entirely by the market's willingness to pay more for each rupee of Rubicon Research Ltd's earnings. That willingness is the story.
Read MoreRubicon Research Ltd is Rated Strong Buy
2026-10-12 10:11:05Rubicon Research Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 12 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreRubicon Research Ltd is Rated Strong Buy
2026-10-01 10:11:07Rubicon Research Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 October 2026, providing investors with the latest insights into its performance and outlook.
Read MoreRubicon Research Ltd Technical Momentum Shifts Amid Strong Year-to-Date Gains
2026-09-28 08:04:54Rubicon Research Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a marginal day decline of 0.07%, the stock’s technical indicators reveal a complex interplay of signals that suggest cautious optimism for investors. With a current price of ₹1,677.15 and a strong Mojo Score of 82.0, upgraded to a Strong Buy rating as of 1 June 2026, the company’s price action and momentum metrics warrant a detailed examination.
Read MoreDisclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) W.R.T Update On The Scheme Of Merger Between Rubicon Research Ltd And KIA Health Tech Pvt Ltd.
14-Nov-2026 | Source : BSEDisclosure under Regulation 30 of SEBI LODR Regulations 2015 (SEBI Regulations) w.r.t update on the Scheme of Merger between Rubicon Research Ltd and KIA Health Tech Pvt Ltd
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12-Nov-2026 | Source : BSETranscript of Earnings Call -Q2 - FY 2026-27
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSENewspaper Publication for Q2 ended September 30 2026 Financial Results
Corporate Actions
No Upcoming Board Meetings
Rubicon Research Ltd has declared 150% dividend, ex-date: 07 Aug 26
No Splits history available
No Bonus history available
No Rights history available